ASHLEY ADES: Open Payments
NPI 1518207950 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 32 payments from 10 companies in 2025. Trend: 2023 $905 · 2024 $1,468 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $381 |
| ABBVIE INC. | 9 | $139 |
| Organon LLC | 2 | $127 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| UCB, Inc. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Amgen Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
Products named: DUPIXENT, VTAMA, Leqselvi, Rhapsido, SKYRIZI, Bimzelx, NEMLUVIO, RINVOQ.
Industry payments across GA — which companies pay providers there.
